Показано 0 из 0
Дата |
---|
16.05.2024 |
15.05.2024 |
14.05.2024 |
13.05.2024 |
10.05.2024 |
09.05.2024 |
08.05.2024 |
07.05.2024 |
06.05.2024 |
03.05.2024 |
Bid | Ask |
Open |
Min | Max |
Last |
Legal close |
Avg |
Оборот |
Кол-во сделок |
---|---|---|---|---|---|---|---|
0.47
|
0.4895
|
0.479
|
0.458
|
0.4948
|
0.489899
|
|
|
15 183.46
|
128.00
|
0.458
|
0.4791
|
0.479
|
0.452
|
0.4791
|
0.458
|
|
|
6 826.76
|
135.00
|
0.4511
|
0.4791
|
0.4653
|
0.4511
|
0.497
|
0.4551
|
|
|
32 583.07
|
138.00
|
0.4503
|
0.49
|
0.481
|
0.47
|
0.4975
|
0.49
|
|
|
7 557.87
|
96.00
|
0.481
|
0.54
|
0.4811
|
0.4811
|
0.513051
|
0.50
|
|
|
2 184.00
|
59.00
|
0.483
|
0.507
|
0.4702
|
0.4702
|
0.5075
|
0.5074
|
|
|
5 691.05
|
87.00
|
0.47
|
0.51
|
0.476
|
0.4722
|
0.487241
|
0.4872
|
|
|
5 881.93
|
64.00
|
0.476
|
0.51
|
0.4995
|
0.46
|
0.50
|
0.476
|
|
|
16 444.72
|
173.00
|
0.466
|
0.50
|
0.492
|
0.4702
|
0.5276
|
0.481
|
|
|
33 930.17
|
174.00
|
0.48
|
0.54
|
0.514
|
0.49
|
0.5276
|
0.501
|
|
|
10 272.81
|
184.00
|
Salarius Pharmaceuticals, Inc. is a clinical-stage oncology company targeting the epigenetic causes of cancers.